Canopy Growth Corporation (TSE:WEED) shares have retraced a considerable 26% in the last month, reversing a fair amount of their solid recent performance. Looking back over the past twelve months the stock has been a solid performer regardless, with a gain of 20%.
In spite of the heavy fall in price, when almost half of the companies in Canada’s Pharmaceuticals industry have price-to-sales ratios (or “P/S”) below 1.2x, you may still consider Canopy Growth as a stock probably not worth researching with its 2.6x P/S ratio. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the elevated P/S.
View our latest analysis for Canopy Growth
What Does Canopy Growth’s P/S Mean For Shareholders?
While the industry has experienced revenue growth lately, Canopy Growth’s revenue has gone into reverse gear, which is not great. One…
